News
Premas Biotech ready to start trials of triple antigen COVID-19 vaccine
The Gurugram-based company is preparing to make available few million doses of the vaccine weekly if Indian regulators approve it quickly through partners or on its own for India’s urgent needs.
DBT-BIRAC COVID-19 Research Consortium recommends 70 proposals for funding in vaccines, diagnostics, therapeutics and other technologies
In addition, BIRAC has also created a provision to fund COVID-19 solutions that are ready for immediate deployment under a ‘Fast Track Review Process’.
5 Indian hospitals to conduct WHO's Solidarity COVID-19 clinical trial of Remdesivir & other drugs
The hospitals will perform clinical trials on at least 1,500 patients the newly repurposed drug such as Remdeisvir that US FDA has given conditional approval last week.
